Search our website

VBI-1901: Phase 2a Data & Clinical Update in Recurrent GBM

November 19, 2020 | Video

Discussion of Data Presented at Society for Neuro-Oncology (SNO) 2020 Annual Meeting
Jeff Baxter, VBI CEO, and Dr. David E. Anderson, Ph.D., VBI CSO

View More Videos

  • VBI-1901: AACR Data and Clinical Update in Recurrent GBM

    Discussion of Data Presented at 2020 American Association for Cancer Research (AACR) Virtual Annual Meeting II

    Watch NowArrow

  • Overview of First- and Second-Generation Hepatitis B Vaccines

    Watch NowArrow

  • Overview of the Design of VBI-1901, VBI’s Therapeutic Cancer Vaccine Candidate

    Watch NowArrow

  • Preclinical Data from VBI-1901, VBI’s Therapeutic Cancer Vaccine Candidate

    Watch NowArrow

  • About Medulloblastoma

    Watch NowArrow

  • About Glioblastoma (GBM)

    Watch NowArrow

  • About Hepatitis B (HBV)

    Watch NowArrow

  • Overview of VBI-1501, VBI’s Cytomegalovirus (CMV) Vaccine Candidate

    Watch NowArrow

  • Overview of VBI’s Enveloped Virus-Like Particle (eVLP) Platform Technology

    Watch NowArrow

Sign-up for Our Distribution List to Receive the Latest News and Updates from VBI

Sign Up NowArrow
Go top